Has anti-D prophylaxis increased the rate of positive direct antiglobulin test results and can the direct antiglobulin test predict need for phototherapy in Rh/ABO incompatibility?

Journal of Paediatrics and Child Health

Volumn 47, Issue 1-2, 2011, Pages 40-43

  Dillon, Alexander ^a   Chaudhari, Tejasvi ^a   Crispin, Phillip ^a,b   Shadbolt, Bruce ^a,b   Kent, Alison ^a  

^a The Australian National University   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

direct Coombs' test; hyperbilirubinemia; jaundice; neonatal; newborn haemolytic disease; Rh prophylaxis

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN; RHESUS D ANTIBODY;

ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; CLINICAL ASSESSMENT; COOMBS TEST; EXCHANGE BLOOD TRANSFUSION; HUMAN; HYPERBILIRUBINEMIA; IMMUNOPROPHYLAXIS; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PHOTOTHERAPY; PRIORITY JOURNAL; RHESUS IMMUNIZATION; RHESUS INCOMPATIBILITY; RISK ASSESSMENT;

AUSTRALIAN CAPITAL TERRITORY; COOMBS' TEST; FEMALE; HUMANS; INFANT, NEWBORN; ISOANTIBODIES; JAUNDICE, NEONATAL; MEDICAL RECORDS; PHOTOTHERAPY; PREDICTIVE VALUE OF TESTS; PREGNANCY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN;

EID: 79251512634     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2010.01888.x     Document Type: Article

References (12)

1. Meberg A, Johansen KB,. Screening for neonatal hyperbilirubinemia and ABO alloimmunization at the time of testing for phenylketonuria and congenital hypothyreosis. Acta Paediatr. 1998; 87: 1269-74.
2. Madan A, Huntsinger K, Burgos A, Benitz W,. Readmission for newborn jaundice: the value of the Coomb's test in predicting the need for phototherapy. Clin. Pediatr. 2004; 43: 63-8.
3. Bhutani VK, Maisels MJ, Stark AR, Buonocore G,. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >/= 35 weeks gestation. Neonatology 2008; 94: 63-7.
4. Han P, Kiruba R, Ong R, Joseph R, Tan KL, Wong HB,. Haemolytic disease due to ABO incompatibility: incidence and value of screening in an Asian population. Aust. Paediatr. J. 1988; 24: 35-8.
5. National Blood Authority. Guidelines on the prophylactic use of Rh D immunoglobulin (anti-D) in obstetrics [homepage on the Internet]. 2003. Available from: [accessed 20 July 2009].
6. Royal Prince Alfred Hospital (RPA). Royal Prince Alfred Hospital-Haemolytic Jaundice Protocol [Homepage on the Internet]. Sydney: RPA, 2003. Available from: [accessed 23 July 2009].
7. Australian and New Zealand Society of Blood Transfusion Ltd. Guidelines for blood grouping and antibody screening in the antenatal and perinatal setting [homepage on the Internet]. 2007; Available from: [accessed 26 July 2009].
8. Levine DH, Belton MH, Meyer P,. Newborn screening for ABO haemolytic disease. Clin. Pediatr. 1985; 24: 391-4.
9. Whyte J, Graham H,. Prediction of the severity of ABO haemolytic disease of the newborn by cord blood tests. Acta Paediatr. 1981; 70: 217-22.
10. American Association of Blood Banks. Technical Manual, 14th edn. Bethesda, MD: AABB Press, 2002.
11. Chandra A, Andrew K, Ryan B,. Antenatal Rh (D) Immunoglobulin (Anti D) Prophylaxis. The Canberra Hospital Maternity Practise Standards. The Canberra Hospital, 2006.
12. Mishra S, Agarwal R, Deorari AK, Vinod P,. Jaundice in the newborns. Indian J. Pediatr. 2008; 75: 157-64.